nafronyl has been researched along with Arteriosclerosis Obliterans in 2 studies
Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.
Arteriosclerosis Obliterans: Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report two cases of acute renal failure in patients with arteriosclerosis obliterans treated by intravenous infusion of naftidrofuryl oxalate." | 1.29 | Potential nephrotoxicity of intravenous infusions of naftidrofuryl oxalate. ( Aldigier, JC; Le Meur, Y; Leroux-Robert, C; Moesch, C; Rincé, M, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Landi, A | 1 |
| Le Meur, Y | 1 |
| Moesch, C | 1 |
| Rincé, M | 1 |
| Aldigier, JC | 1 |
| Leroux-Robert, C | 1 |
1 review available for nafronyl and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
[Secondary prevention and conservative therapy of obliterative arteriosclerosis].
Topics: Arteriosclerosis Obliterans; Cilostazol; Clinical Trials as Topic; Epoprostenol; Exercise; Hematolog | 2004 |
1 other study available for nafronyl and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
Potential nephrotoxicity of intravenous infusions of naftidrofuryl oxalate.
Topics: Acute Kidney Injury; Arteriosclerosis Obliterans; Calcium Oxalate; Crystallization; Humans; Infusion | 1995 |